Laboratory tests of a novel serotonin-binding compound have revealed an unexpected disconnect between receptor activation and ...

Researchers have developed a new model to study the antidepressant and anti-anxiety effects of psilocybin in mice.

A research team from UNC-Chapel Hill, UC San Francisco, Yale, Duke, and Stanford developed a new compound that hits the same brain cell target as psychedelic drugs, triggering long-lasting ...

Ithaca, NY - Rates of anxiety and depression have been increasing around the world for decades, a trend that has been sharply exacerbated by the COVID-19 pandemic. New research led by the Boyce ...

Psilocybin—the psychedelic compound that occurs naturally in certain "magic" mushroom species—has been shown in trials to ...

Classical psychedelics act on a surprisingly broad range of brain receptors, not just the serotonin receptor long associated with their hallucinogenic effects, according to new research published in ...

A major paper debunking the “serotonin hypothesis” has a lot of people agitated. But leaving more room for nuance in our discussions about mental health is the right idea. Building a more complex, ...

An appetite-suppressing chemical also improves glucose tolerance and lowers insulin levels in obese and diabetic mice, researchers report in the November issue of Cell Metabolism, a publication of ...

Currently, various classes of drugs are available for the treatment of mental illnesses - such as depression and anxiety disorders. However, although these drugs confer benefits, they are also ...

UC Davis researchers have developed a new method that uses light to transform amino acids - the building blocks of proteins - into molecules that are similar in structure to psychedelics and mimic ...